• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Neurenati`s NEU-001 Receives EMA Orphan Drug Designation

    BUSINESSWIRE

    Neurenati`s First Scientific Advisory Board Meeting for NEU-001

    BUSINESSWIRE

    FDA Grants Orphan, Rare Pediatric Status To NEU-001 For Hirschsprung

    BUSINESSWIRE

    Neurenati Therapeutics: Board Strengthening with Dr. Cohard-Radice

    BUSINESSWIRE

    Neurenati Therapeutics Raises $1.7M In Second Seed Funding Round

    BUSINESSWIRE

    Neurenati Therapeutics Concludes a 1.2 Million $ Seed Financing Round

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.